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IT HAS been shown that clorindione (2-(4'-chlorphenyl)-indanedione-(1.3)) is a long acting anticoagulant. Lund (1957) , Strobel (1962) and Poller and O'Brien (1962) demonstrated that it required 2-3 days for the prothrombin activity to be depressed to within the therapeutically effective range. It was shown Iby Strobel that the prothrombin activity increases to above the range after 4 days and 'becomes normal 6 days after a single dose of clorindione. He also gives details of the physical 'and chemical properties of the drug.
The purpose of this investigation was to assess the value of this anticoagulant in 'both inpatient and outpatient treatment of thrombo-embolic diseases.
Methods
The drug was administered to 32 patients. From the start of the trial it was given to all patients considered to need anticoagulant treatment unless at the time of admission they were being treated with another anticoagulant or unless there were the usual contradictions such as indigestion. No 
